State Street Corp I Mab Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.58 - $1.9 $11,710 - $14,082	-7,412 Reduced 6.72%	102,961 $171,000
Q1 2024 May 15, 2024	BUY	$1.54 - $2.37 $13,357 - $20,557	8,674 Added 8.53%	110,373 $205,000
Q4 2023 Feb 14, 2024	BUY	$1.21 - $1.9 $2,630 - $4,130	2,174 Added 2.18%	101,699 $193,000
Q3 2023 Nov 14, 2023	SELL	$1.18 - $3.06 $480,386 - $1.25 Million	-407,107 Reduced 80.36%	99,525 $131,000
Q2 2023 Aug 14, 2023	SELL	$2.95 - $3.85 $40,240 - $52,517	-13,641 Reduced 2.62%	506,632 $1.51 Million
Q1 2023 May 15, 2023	BUY	$3.08 - $7.39 $100,703 - $241,623	32,696 Added 6.71%	520,273 $1.8 Million
Q4 2022 Feb 14, 2023	BUY	$3.22 - $4.86 $19,123 - $28,863	5,939 Added 1.23%	487,577 $2.04 Million
Q3 2022 Nov 15, 2022	SELL	$4.01 - $12.34 $4,675 - $14,388	-1,166 Reduced 0.24%	481,638 $1.93 Million
Q2 2022 Aug 15, 2022	SELL	$8.27 - $18.43 $2.22 Million - $4.95 Million	-268,450 Reduced 35.73%	482,804 $5.46 Million
Q1 2022 May 16, 2022	BUY	$12.54 - $46.93 $1.6 Million - $6 Million	127,890 Added 20.52%	751,254 $12.2 Million
Q4 2021 Feb 14, 2022	BUY	$45.28 - $74.5 $3.45 Million - $5.67 Million	76,142 Added 13.91%	623,364 $29.5 Million
Q3 2021 Nov 15, 2021	BUY	$57.18 - $84.43 $6 Million - $8.86 Million	104,897 Added 23.71%	547,222 $39.7 Million
Q2 2021 Aug 16, 2021	BUY	$47.86 - $83.95 $20.3 Million - $35.7 Million	424,738 Added 2415.07%	442,325 $37.1 Million
Q1 2021 May 17, 2021	BUY	$44.38 - $63.97 $101,852 - $146,811	2,295 Added 15.01%	17,587 $852,000
Q4 2020 Feb 16, 2021	BUY	$32.94 - $47.15 $503,718 - $721,017	15,292 New	15,292 $721,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

15.5M

Call Options Held

56.4K

Put Options Held

5.8K

Hhlr Advisors, Ltd. Grand Cayman, E9

6.91M
Shares

$6.56 Million
0.2% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.17M
Shares

$3.96 Million
3.04% of portfolio
Boothbay Fund Management, LLC New York, NY

1.42M
Shares

$1.35 Million
0.05% of portfolio
Temasek Holdings (Private) LTD Singapore, U0

567K
Shares

$538,317
0.0% of portfolio
David A. Siegel Two Sigma Advisers, LP | New York, Ny

499K
Shares

$474,335
0.0% of portfolio

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $78.9M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account